{
    "clinical_study": {
        "@rank": "139461", 
        "arm_group": [
            {
                "arm_group_label": "LiMAx-group", 
                "arm_group_type": "Experimental", 
                "description": "Intravenous pre- and post-surgical injection of 0.4% 13-C-Methacetin solution. Dosage is adapted due to body weight (2 mg/kg). A LiMAx-test of >150 \u00b5g/kg/h would correspond to a general ward indication."
            }, 
            {
                "arm_group_label": "control group", 
                "arm_group_type": "No Intervention", 
                "description": "Control group without intervention. Post-surgical management as defined prior to surgery following well-established clinical standards."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate safety and efficacy of intravenously injected\n      0.4% 13-C-Methacetin solution for the determination of liver function with the LiMAx-test on\n      patients with partial liver resection. The LiMAx-test is compared with an untreated control\n      group and post-surgical management of both groups is investigated."
        }, 
        "brief_title": "Fast-track LiveR: Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Liver Failure", 
        "condition_browse": {
            "mesh_term": "Liver Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male or female patients of 18 years or older which are able to give informed consent\n             with indication for surgical partial liver resection according to OPS code 5-502;\n             this includes benign and malign tumors.\n\n          -  patients with pre-surgical thin-layer CT or MRT of the liver not older than 6 weeks\n             or patients where a pre-surgical thin-layer CT or MRT of the liver is planned before\n             surgery.\n\n          -  written informed consent\n\n        Exclusion Criteria:\n\n        at screening:\n\n          -  anamnestic known hypersensitivity against one of the study drugs, their ingredients\n             or drugs with chemically similar structure (in particular paracetamol)\n\n          -  participation in another clinical trials within 4 weeks before inclusion\n\n          -  patients with previous liver surgery (OPS-Code 5-502), including biliodigestive\n             anastomosis, excluding cholecystectomy.\n\n          -  patients which underwent interventions such as radiofrequency ablation, biopsies or\n             smaller surgeries within 6 weeks before inclusion\n\n          -  patients anticipated for biliodigestive anastomosis and/or suffering from a\n             Klatskin-tumor\n\n          -  patients with a ASA (American Society of Anesthesiologists) classification >3\n\n          -  patients anticipated for laparoscopic partial liver resection\n\n          -  patients which are intended to be simultaneously treated with an interventional\n             technique (e.g. radio frequency ablation RFA, embolization)\n\n          -  patients which are intended to simultaneously get a surgery on other organs\n             (excluding cholecystectomy)\n\n          -  patients which are intended to simultaneously get a vascular anastomosis (e.g. portal\n             vein resection)\n\n          -  patients with known hepatic cirrhosis or known severe fibrosis (e.g. Ishak-score\n             grade >4)\n\n          -  patients with congenital metabolic diseases, in particular hepatic storage diseases\n\n          -  hepatic infection with Echinococcus multilocularis\n\n          -  patients with known non-infectious, auto-immune conditioned chronic inflammatory\n             diseases (e.g. autoimmune hepatitis, Morbus Crohn, colitis ulcerativa)\n\n          -  patients with severe cardiovascular diseases and/or severe diseases of the\n             respiratory system which receive intensive care in any case (e.g. heart surgery,\n             bypass surgery, cardiac valve replacement, unstable angina pectoris, severe coronary\n             heart disease with intervention during the last 6 months, severe COPD (chronic\n             obstructive pulmonary disease), severe asthma with concomitant cortisone medication)\n\n          -  patients with severe bacterial infection at screening\n\n          -  patients with known immunodeficiency\n\n          -  heavy smokers (>20 cigarettes a day)\n\n          -  patients which are unable to understand the study and its possible implications\n             because of addiction or other diseases\n\n          -  patients who are suspected not to cooperate or to comply to the trial protocol\n\n          -  patients accommodated in an institution due to public or legal authority\n\n          -  pregnant or lactating women\n\n          -  women with child-bearing potential, excluding: negative pregnancy test and commitment\n             to be sexually inactive until day 30 after surgery or discharge; postmenopause (12\n             months of natural occurring amenorrhoea); at least 6 weeks after ovariectomy with or\n             without hysterectomy\n\n        at visit 2:\n\n          -  patients anticipated for laparoscopic partial liver resection\n\n          -  patients which are intended to be simultaneously treated with an interventional\n             technique (e.g. radio frequency ablation RFA, embolization)\n\n          -  patients which are intended to simultaneously get a surgery on other organs\n             (excluding cholecystectomy)\n\n          -  patients which are intended to simultaneously get a vascular anastomosis (e.g. portal\n             vein resection)\n\n          -  patients with known hepatic cirrhosis or known severe fibrosis (e.g. Ishak-score\n             grade >4)\n\n          -  hepatic infection with Echinococcus multilocularis\n\n          -  patients with severe cardiovascular diseases and/or severe diseases of the\n             respiratory system which receive intensive care in any case (e.g. heart surgery,\n             bypass surgery, cardiac valve replacement, unstable angina pectoris, severe coronary\n             heart disease with intervention during the last 6 months, severe COPD (chronic\n             obstructive pulmonary disease), severe asthma with concomitant cortisone medication)\n\n          -  patients anticipated for biliodigestive anastomosis and/or suffering from a\n             Klatskin-tumor\n\n          -  patients with a ASA (American Society of Anesthesiologists) classification >3"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785082", 
            "org_study_id": "HUM-001"
        }, 
        "intervention": {
            "arm_group_label": "LiMAx-group", 
            "description": "intravenous injection of 0.4% 13-C-Methacetin solution, once before partial liver resection, once after partial liver resection", 
            "intervention_name": "13-C-Methacetin", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "13-C-Methacetin", 
            "partial liver resection", 
            "liver function tests"
        ], 
        "lastchanged_date": "October 10, 2013", 
        "location": [
            {
                "contact": {
                    "email": "martin.stockmann@charite.de", 
                    "last_name": "Martin Stockmann, PD Dr. med.", 
                    "phone": "+49-30-450552001"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Dept. of General-, Visceral- and Graft Surgery, Charit\u00e9 Campus Virchow-Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Martin Stockmann, PD Dr. med.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Gerhard Hunold, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Maximilian Jara", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Maciej Malinowski, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Sascha Chopra, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "utz.settmacher@med.uni-jena.de", 
                    "last_name": "Utz Settmacher, Prof. Dr.", 
                    "phone": "+49-36419322601"
                }, 
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany", 
                        "zip": "07747"
                    }, 
                    "name": "Dept. of General- and Visceral Surgery, Jena University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Utz Settmacher, Prof. Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Alen Nikolic, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Astrid Bauschke, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rene Fahrner, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Alexander Koch", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Vyron Mategakis", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Lawrence Mutwol, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Falk Rauchfu\u00df, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Hubert Scheuerlein, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ulrike Sch\u00f6ne, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Frank Ute\u00df", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hans-michael.tautenhahn@medizin.uni-leipzig.de", 
                    "last_name": "Hans-Michael Tautenhahn", 
                    "phone": "0341-9717185"
                }, 
                "facility": {
                    "address": {
                        "city": "Leipzig", 
                        "country": "Germany", 
                        "zip": "04103"
                    }, 
                    "name": "Clinic and Policlinic for Visceral-, Graft-, Thorax- and Vascular Surgery, Leipzig University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Hans-Michael Tautenhahn", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Michael Bartels, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Georgi Atanasov", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Christian Benzing", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Julian Bucher, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Moritz Schmelzle, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Markus Schoenberg, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Katrin Semmling", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Georg Wiltberger, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Lock_J@chirurgie.uni-wuerzburg.de", 
                    "last_name": "Johan F. Lock, Dr.", 
                    "phone": "0931-20131181"
                }, 
                "facility": {
                    "address": {
                        "city": "W\u00fcrzburg", 
                        "country": "Germany", 
                        "zip": "97080"
                    }, 
                    "name": "Clinic and Policlinic for General- Visceral- and Graft Surgery, W\u00fcrzburg University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Johan F. Lock, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ingo Klein, Prof.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Klaus-Ulrich Steger, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test", 
        "other_outcome": {
            "description": "Pre-surgical volumetric analysis of liver and tumor by CT or MRT and post-surgical volumetric analysis of the resected liver.", 
            "measure": "pre- and post-surgical volumetric analysis of the liver", 
            "safety_issue": "No", 
            "time_frame": "immediately pre and post surgery"
        }, 
        "overall_contact": {
            "email": "brigitte.hoch@humedics.de", 
            "last_name": "Brigitte Hoch, Dr.", 
            "phone": "+49-30-590083249"
        }, 
        "overall_official": {
            "affiliation": "Dept. of General-, Visceral- and Graft Surgery, Charit\u00e9 Campus Virchow-Hospital, Augustenburger Platz 1, 13353 Berlin, Germany", 
            "last_name": "Martin Stockmann, PD Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Germany: Ethics Commission"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correctly determined positive patients are patients which are transferred to general ward after surgery because of the result of the LiMAx-test (LiMAx-group) or general diagnosis (control group). Patients have to stay at general ward until discharge no later than day 30 after surgery.", 
            "measure": "number of correctly determined positive patients in each trial group", 
            "safety_issue": "Yes", 
            "time_frame": "no later than day 30 after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785082"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Incorrectly determined positive patients are patients which are transferred to general ward after surgery because of the result of the LiMAx-test or general diagnosis (control group) and do not stay at general ward until discharge or are discharged later than 30 days after surgery.", 
                "measure": "number of incorrectly determined positive patients in each trial group", 
                "safety_issue": "Yes", 
                "time_frame": "no later than day 30 after surgery"
            }, 
            {
                "description": "number of correctly predicted positive patients / (number of correctly predicted positive patients + number of incorrectly predicted negative patients)", 
                "measure": "sensitivity", 
                "safety_issue": "No", 
                "time_frame": "1 year after trial start (anticipated December 2013)"
            }, 
            {
                "description": "number of correctly predicted negative patients / (number of correctly predicted negative patients + number of incorrectly predicted positive patients)", 
                "measure": "specificity", 
                "safety_issue": "No", 
                "time_frame": "1 year after trial start (anticipated December 2013)"
            }, 
            {
                "description": "number of correctly predicted positive patients / (number of correctly predicted positive patients + number of incorrectly predicted positive patients)", 
                "measure": "positive predictive value (PPV)", 
                "safety_issue": "No", 
                "time_frame": "1 year after trial start (anticipated December 2013)"
            }, 
            {
                "description": "number of correctly predicted negative patients / (number of correctly predicted negative patients + number of incorrectly predicted negative patients)", 
                "measure": "negative predictive value (NPV)", 
                "safety_issue": "No", 
                "time_frame": "1 year after trial start (anticipated December 2013)"
            }, 
            {
                "description": "total mortality until day 30 post-surgical", 
                "measure": "mortality", 
                "safety_issue": "Yes", 
                "time_frame": "1 year after trial start (anticipated December 2013)"
            }, 
            {
                "description": "PHLF according to the Rahbari-Score", 
                "measure": "number of patients with post-surgical liver failure (PHLF)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year after trial start (anticipated December 2013)"
            }, 
            {
                "description": "total number of complications of grade IIIa (surgical, endoscopic or radiological intervention) to grade V (death)", 
                "measure": "total number of complications", 
                "safety_issue": "Yes", 
                "time_frame": "1 year after trial start (anticipated December 2013)"
            }, 
            {
                "description": "assessment of clinical data (sodium, potassium, creatinine, urea, protein, albumin, total bilirubin, AST, ALT, AP, GGT, blood count, INR, PTT). In addition, clinical data as pulse or blood pressure are recorded.", 
                "measure": "changes of routine laboratory data", 
                "safety_issue": "Yes", 
                "time_frame": "until day 30 after surgery"
            }
        ], 
        "source": "Humedics GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Humedics GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}